Associate Scientist, Molecular Biology and Protein Expression – NGM Biopharmaceuticals – South San Francisco, CA

These programs include MK-3655 in a phase 2b clinical study in patients with non-alcoholic steatohepatitis (NASH) and liver fibrosis stage...

Click to view original post